5
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6229 |
Daclatasvir
Daklinza,达卡他韦,EBP 883,达拉他韦,BMS-790052 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Daclatasvir (EBP 883) 是一种高度选择性的 HCV NS5A 抑制剂,EC50 为 9-50 pM,适用于细胞培养中的多种 HCV 复制子基因型和 JFH-1 基因型 2a 感染性病毒。 | |||
T1786 |
Daclatasvir dihydrochloride
BMS-790052 dihydrochloride,盐酸达拉他韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) 是有机阴离子转运多肽 1B(OATP1B) 和 OATP1B3抑制剂,IC50分别为 1.5 µM 和 3.27 µM。它也具有口服活性的 HCV NS5A 蛋白抑制剂,多种 HCV 复制子基因型的 EC50范围为 9-146 pM。 | |||
T22680 |
CP-100356 hydrochloride
CP-100356 HCl,CP 100356 hydrochloride |
BCRP | Membrane transporter/Ion channel |
CP-100356 hydrochloride 是一种具有口服活性和低微摩尔的 MDR1 (P-gp) 和 BCRP 双重抑制剂,是核苷酸衍生的底物类似物,对 MDR1 介导的 Calcein-AM 转运 和 BCRP 介导的 Prazosin 转运有抑制作用。CP-100356 抑制 OATP1B1,可在黑暗中诱导气孔张开。 | |||
T79520 |
HMG-CoA Reductase-IN-1
|
||
HMG-CoA Reductase-IN-1是一种HMG-CoA还原酶抑制剂,显示出高HMGR抑制活性及OATP1B1亲和力,具有pIC50值8.54和pKm值1.98。该化合物适用于高胆固醇血症的研究。 | |||
T36746 |
Leoidin
|
||
Leoidin is a depsidone originally isolated from L. gangaleoides that has antibacterial and enzyme inhibitory activities.1,2,3 It is active against the bacteria E. faecalis, H. influenzae, M. catarrhalis, S. aureus, and S. pneumoniae (MICs = 8, 32, 1, 128, and 64 μg/ml, respectively).2 Leoidin inhibits phenylalanyl-tRNA synthetase (PheRS) isolated from P. aeruginosa (IC50 = 42 μM). It also inhibits organic anion-transporting polypeptide 1B1 (OATP1B1) and OATP1B3 with Ki values of 0.08 and 1.84 μM... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3880 |
Silydianin
水飞蓟宁,Silidianin |
Phosphatase | Metabolism |
Silydianin (Silidianin) 是一种水飞蓟的活性成分,具有抗胶原酶和抗弹性酶作用,对氧化产物的体外产生和释放具有抑制作用 。它是一种天然蛋白酪氨酸磷酸酶 1B 抑制剂,其IC50=17.38 μM。 | |||
T38805 |
Euphol acetate
|
||
Euphol acetate, a triterpene found in Euphorbia broteri, has demonstrated inhibitory effects on the hepatic transport proteins known as organic anion-transporting polypeptide 1/3 (OATP1B1/3). |